Network origin in Joshua Friedman first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Joshua Friedman via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal | |
SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SALIX PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | President | |
ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Director of Finance/CFO | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
SHIRE | Pharmaceuticals: Major | Director of Finance/CFO | |
PellePharm, Inc.
PellePharm, Inc. BiotechnologyHealth Technology PellePharm, Inc. engages in the operation of a biotechnology company committed to targeting rare dermatologic diseases. It develops Patidegib , an investigational topical treatment designed to mitigate the tumor burden in patients with Gorlin Syndrome and Basal Cell Carcinomas (BCCs), and other potential indications. The firm also focuses on commercializing Patidegib treatment by potentially reducing invasive and painful surgeries. The company was founded by Michael Henderson, Jean Tang, Ervin Epstein, and Philip Beachy and is headquartered in San Francisco, CA. | Biotechnology | Founder | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Dartmouth College | College/University | Undergraduate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Stanford University | College/University | Doctorate Degree | |
Baker Botts LLP
Baker Botts LLP Miscellaneous Commercial ServicesCommercial Services Baker Botts LLP provides legal services. Its services include antitrust and compensation law, corporate, enforcement and investigations, environmental law, intellectual property, litigation, projects, real estate and construction, regulatory, and tax. The firm renders its services to banking and finance industry, energy and natural resources, manufacturing, and technological industries. The company was founded by Peter Gray in 1840 and is headquartered in Houston, Texas. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
MIRATI THERAPEUTICS | Biotechnology | Director of Finance/CFO | |
Arizona State University | College/University | Undergraduate Degree Undergraduate Degree | |
Azusa Pacific University | College/University | Masters Business Admin | |
Haverford College | College/University | Undergraduate Degree | |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Klauber & Jackson Llc
Klauber & Jackson Llc Miscellaneous Commercial ServicesCommercial Services Klauber & Jackson Llc is a private company based in Hackensack, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Therasis, Inc.
Therasis, Inc. Pharmaceuticals: MajorHealth Technology Therasis, Inc. develops oncology drugs. It offers oncology therapeutics for use as single agents or in combination therapy. The firm's proprietary technology, the Therasis Filter, represents a paradigm shift in the ability to discover therapeutic targets, their chemical inhibitors, and associated biomarkers and this platform integrates world-class expertise in high throughput screening, systems biology, cancer genetics and clinical research. The company was founded by Owen A. O'Connor and Riccardo Dalla-Favera in 2007 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Ropes & Gray LLP
Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Ropes & Gray LLP provides legal and private equity services. Its practice areas include asset management, banking, business and commercial litigation, business restructuring, capital markets and corporate governance and compliance. The company was founded in 1865 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AXCA HEALPAR | Biotechnology | General Counsel General Counsel | |
Cornell Law School | College/University | Graduate Degree | |
PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
SURFACE ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
Shire International GmbH (Switzerland)
Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Pharmaceuticals: Major | Investor Relations Contact | |
VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
PROVENTION BIO, INC. | Pharmaceuticals: Major | General Counsel | |
PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Chief Executive Officer | |
ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
QED Therapeutics, Inc.
QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., QED Therapeutics, Inc. is a biotechnology company based in Palo Alto, CA. The company focuses on precision medicine for FGFR-driven diseases and is committed to finding solutions to FGFR-driven cancers and diseases to give patients more possibilities. QED Therapeutics' lead investigational candidate is infigratinib, an orally administered, FGFR1-3 selective tyrosine kinase inhibitor that has shown activity in patients with chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions and advanced urothelial carcinoma with FGFR3 genomic alterations. In 2020, QED submitted a new drug application (NDA) with the Food and Drug Administration for second- and later-line cholangiocarcinoma. Michael Henderson has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chief Executive Officer | |
Origin Biosciences, Inc.
Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Origin Biosciences, Inc. is an actively managed investment issuer focused on making equity investments in psychedelics industry-related companies to provide investors with diverse exposure to the sector. The company is based in Palo Alto, CA. The company, led by a team of industry experts, leverages its management expertise, professional network, and due diligence process to identify and invest in leading and emerging companies focused on the emerging psychedelics sector. Michael Henderson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Chief Executive Officer | |
Navire Pharma, Inc.
Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Navire Pharma, Inc. engages in the development of therapeutics to treat multiple cancers. It focuses on SHP2, a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signalling with the downstream RAS/ERK MAPK pathway to regulate cellular proliferation and survival. The company was founded by Phil Jones and Benjamin Neel in 2017 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chief Operating Officer | |
Viridian LLC
Viridian LLC BiotechnologyHealth Technology Viridian LLC operates as a biopharmaceutical incubator. It focuses in the discovery and development of new molecular entities. The company was founded by Peter Harwin and Tomas Kiselak in 2016 and is headquartered in Philadelphia, PA. | Biotechnology | Founder Founder | |
BRIDGEBIO PHARMA, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
APOGEE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Chairman | |
DIANTHUS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
ARYA SCIENCES ACQUISITION CORP IV | Financial Conglomerates | Director/Board Member | |
Rebalance Health, Inc.
Rebalance Health, Inc. Pharmaceuticals: OtherHealth Technology Rebalance Health, Inc. is a company that offers a sleep aid product called Meet Dream, which is made of natural and organic ingredients. The company is based in Boulder, CO and was founded by Justin A. Hai, who has been the CEO since incorporation. The product is designed to provide a restorative sleep experience every night and has been clinically tested to reduce hot flashes, lower anxiety, and unleash testosterone. | Pharmaceuticals: Other | Director/Board Member | |
LONGBOARD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Writeboston | Director/Board Member |
Statistics
International
United States | 43 |
Ireland | 2 |
Switzerland | 2 |
Sectoral
Health Technology | 30 |
Consumer Services | 8 |
Commercial Services | 7 |
Finance | 2 |
Operational
Director/Board Member | 59 |
Corporate Officer/Principal | 39 |
Independent Dir/Board Member | 28 |
Undergraduate Degree | 12 |
Chairman | 11 |
Most connected contacts
Insiders | |
---|---|
Alison Lawton | 24 |
Jeffrey Albers | 14 |
Michael Henderson | 14 |
Russell Cox | 13 |
Laurie Stelzer | 13 |
Peter Harwin | 11 |
Mark Mckenna | 11 |
Tomas Kiselak | 10 |
Cameron Turtle | 10 |
Paul Fehlner | 10 |
Heidy Abreu King-Jones | 8 |
Scott Burrows | 4 |
Scott W. Rowlinson | 2 |
Deanna Nguyen | 1 |
Mira Huyghe | 1 |
- Stock Market
- Insiders
- Joshua Friedman
- Company connections